Differential indication for SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with established atherosclerotic heart disease or at risk for congestive heart failure
Year: 2019
Type: review
Source: Metabolism
Institutions: University of Bari Aldo Moro, Universitätsklinikum Aachen
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G408933901
OpenAlex ID: W2992147736
